LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.

Revenue
+25.3%
EPS
+2,042.9%
Free cash flow
+31.6%
Total debt
−5.15%

Quarter to September 2026, against a year earlier

13.44 0.77 −5.42%
Market cap
$5.1B
P/E
70.7×
Fwd P/E
81.1×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a

LifeStance Health Group, Inc. (LFST) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, LifeStance Health Group, Inc. (LFST) trades at a P/S ratio of 3.1×. Over the past ten years it has ranged from 1.1× (August 2025) to 19.7× (June 2021); the current reading is higher than 69% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.9× (14.58%)
FY2024 2.2× (18.77%)
FY2023 2.7× 43.07%
FY2022 1.9× (58.85%)
FY2021 4.7× (68.78%)
FY2020 15.0× 0.00%
FY2019 15.0× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 2.7× 5.52%
Jun 2026 2.6× 57.04%
Mar 2026 1.7× (13.51%)
Dec 2025 1.9× 22.60%
23 more quarters

Against its own ten years

Low 1.1× High 19.7×
Ten-year median 2.4×
Current reading's percentile 69

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LFST